IL-12-independent costimulation pathways for interferon-γ production in familial disseminated Mycobacterium avium complex infection

Clinical Immunology

Volumn 91, Issue 2, 1999, Pages 234-241

  Frucht, David M ^a   Sandberg, David I ^a   Brown, Margaret R ^b   Gerstberger, Susan M ^a   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12;

ACCESSORY CELL; ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL TRANSFORMATION; FAMILIAL DISEASE; GENETIC SUSCEPTIBILITY; IMMUNOCOMPETENT CELL; MOLECULAR INTERACTION; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING;

EID: 0032927842     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4688     Document Type: Article

References (34)

1. Flynn J. L., Chan J., Triebold K. J., Dalton D. K., Stewart T. A., Bloom B. R. An essential role for interferon-γ in resistance toMycobacterium tuberculosis. J. Exp. Med. 178:1993;2249.
2. Cooper A. M., Dalton D. K., Stewart T. A., Griffen J. P., Russell D. G., Orme I. M. Disseminated tuberculosis in interferon-γ gene-disrupted mice. J. Exp. Med. 178:1993;2243.
3. Kamijo R., Le J., Shapiro D., Havell E. A., Huang S., Aguet M., Bosland M., Vilcek J. Mice that lack the interferon-γ receptor have profoundly altered responses to infection with bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1993;1435.
4. Newport M. J., Huxley C. M., Huston S., Hawrylowicz C. M., Oostra B. A., Williamson R., Levin M. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1996;1941-1949.
5. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J. F., Newport M., Levin M., Blanche S., Seboun E., Fischer A., Casanova J. L. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335:1996;1956-1961.
6. Dorman S., Holland S. M. Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection. J. Clin. Invest. 101:1998;2364-2369.
7. Kobayashi M., Fitz L., Ryan M., Hewick R. M., Clark S. C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:1989;827.
8. Pryjma J., Ernst M., Fetting R., Woloszyn M., Zembala M., Flad H. D. The role of monocytes in the induction and regulation of IFN-γ production by lectin-activated human T lymphocytes. Eur. Cytokine Net. 2:1991;273-279.
9. Stern A. S., Podlaski F. J., Hulmes J. D., Pan Y. E., Quinn P. M., Wolitzky A. G., Familletti P. C., Stremlo D. L., Truitt T., Chizzonite R., Gately M. K. Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 87:1990;6808.
10. Kubin M., Kamoun M., Trinchieri G. Interleukin-12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J. Exp. Med. 180:1994;211.
11. Wingren A. G., Dahlenborg K., Bjorklund M., Hedlund G., Kalland T., Sjogren H., Ljungdahl A., Olsson T., Ekre H., Sansom D., Dohlsten M. Monocyte-regulated IFN-γ production in human T cells involves CD2 signaling. J. Immunol. 151:1993;1328.
12. Murphy E. E., Terres G., Macatonia S. E., Hsieh C., Mattson J., Lanier L., Wysocka M., Trinchieri G., Murphy K., O'Garra A. B7 and interleukin 12 cooperate for proliferation and interferon production by mouse T helper clones that are unresponsive to B7 costimulation. J. Exp. Med. 180:1994;223.
13. Frucht D. M., Holland S. M. Defective monocyte costimulation for IFN-γ production in familial disseminatedMycobacterium avium. J. Immunol. 157:1996;411.
14. Holland S. M., Eisenstein E. M., Kuhns D. B., Turner M. L., Fleisher T. A., Strober W., Gallin J. I. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. N. Engl. J. Med. 330:1994;1348.
15. Kato T., Hakamada R., Yamane H., Nariuchi H. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction. J. Immunol. 156:1996;3932.
16. Shu U., Kiniwa M., Wu C. Y., Maliszewski C., Vezzio N., Hakimi J., Gately M., Delespesse G. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1995;1125.
17. Lozzio C., Lozzio B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. 45:1975;321.
18. Sundstrom C., Wilson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. 17:1976;565.
19. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment of characterization of a human acute monocytic leukemia cell line (THP1). Int. J. Cancer. 26:1980;171.
20. Yang Y., Wilson J. M. CD40 ligand-dependent T cell activation: Requirement of B7-CD28 signaling through CD40. Science. 273:1996;1862.
21. Grewal I. S., Foellmer H. G., Grewal K. D., Xu J., Hardardottir F., Baron J. L., Janeway C. A., Flavell R. A. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science. 273:1996;1864.
22. +. Eur. J. Immunol. 24:1994;3148.
23. Kiener P. A., Moran-Davis P., Rankin B. M., Wahl A. F., Aruffo A., Hollenbaugh D. Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J. Immunol. 155:1995;4917.
24. +. J. Immunol. 152:1994;1523.
25. Campbell K. A., Ovendale P. J., Kennedy M. K., Fanslow W. C., Reed S. G., Maliszewski C. R. CD40 ligand is required for protective cell-mediated immunity toLeishmania major. Immunity. 4:1996;283.
26. Kamanaka M., Yu P., Yasui T., Yoshida K., Kawabe T., Horii T., Kishimoto T., Kikutani H. Protective role of CD40 inLeishmania major. Immunity. 4:1996;275.
27. Stout R. D., Suttles J., Xu J., Grewal I. S., Flavell R. A. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J. Immunol. 156:1996.
28. Alderson M. R., Armitage R. J., Tough T. W., Strockbine L., Fanslow W. C., Spriggs M. K. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J. Immunol. 178:1993;669.
29. Armant M., Ishihara H., Rubio M., Delespesse G., Sarfati M. Regulation of cytokine production by soluble CD23: Costimulation of interferon-γ secretion and triggering of tumor necrosis factor α release. J. Exp. Med. 180:1994;1005.
30. Armant M., Rubio M., Delespesse G., Sarfati M. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J. Immunol. 155:1995;4868.
31. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378:1995;88.
32. Magram J., Connaughton S. E., Warrier R. R., Carvajal D. M., Wu C., Ferrante J., Stewart C., Sarmiento U., Faherty D. A., Gately M. K. IL-12 deficient mice are defective in IFNγ production and type 1 cytokine response. Immunity. 4:1996;471.
33. Altare F., Durandy A., Lammas D. Impairment of mycobacterial immunity in human interleukin 12 receptor deficiency. Science. 280:1998;1432-1434.
34. De Jong R., Altare F., Haagen I. Severe mycobacterial and Salmonella infections in interleukin 12 receptor deficient patients. Science. 280:1998;1435-1438.